PBLA – panbela therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Panbela Therapeutics, Inc. (NASDAQ: PBLA) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
Panbela Provides Business Update and Reports Q1 2024 Financial Results [Yahoo! Finance]
Panbela Provides Business Update and Reports Q1 2024 Financial Results
Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac
Panbela to Host First Quarter 2024 Earnings Conference Call on May 15, 2024
Form 424B3 Panbela Therapeutics,
Form 424B3 Panbela Therapeutics,
Form 424B3 Panbela Therapeutics,
Form 424B3 Panbela Therapeutics,
Form 424B3 Panbela Therapeutics,
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.